+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04790253

Comparing Prophylactic Cranial Irradiation and Brain MRI Surveillance for Small Cell Lung Cancer Patients to Assess Survival and Cognitive Outcomes

Led by European Organisation for Research and Treatment of Cancer - EORTC · Updated on 2026-10-16

600

Participants Needed

55

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatments for small cell lung cancer SCLC patients to determine if brain magnetic resonance imaging MRI surveillance alone is not worse than prophylactic cranial irradiation PCI combined with brain MRI surveillance in terms of overall survival. This phase III study also examines cognitive failure-free survival, quality of life, and safety between these two approaches. The study includes patients with limited and extensive stages of SCLC who have completed standard therapy without disease progression. Participants are randomly assigned to one of two groups. One group receives prophylactic cranial irradiation at 25 Gy in 10 fractions to the whole brain along with scheduled brain MRIs before randomization and at 3, 6, 9, 12, 18, and 24 months. The other group undergoes active brain MRI surveillance on the same schedule without PCI. Clinical evaluations occur every 3 months, and extracranial imaging is performed as per physician discretion. During the study, participants undergo repeated brain MRIs, clinical evaluations, and imaging to monitor cancer progression and brain metastases. Researchers assess overall survival, cognitive function, quality of life, toxicity severity, and cost-effectiveness over 12 months. Blood samples are collected for biobanking. The total study duration extends up to April 2028, with ongoing monitoring of health status and adverse effects throughout participation.

CONDITIONS

Brief Title

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

Research Team

E

EORTC Reception

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here